BHCUX Mutual Fund

NAV$22.48
Showing top 15 of 41 holdingsSee all 41 holdings(as of Mar 31, 2026)
#Ticker ↕Name ↕Weight ↓Shares ↕Mkt Value ↕Share ChgPROSectorPROIndustryPRO
1LLYEli Lilly And Company9.95%13,000$11.96M-Health CarePharmaceuticals
2AZN:LNAstrazeneca Plc Adr5.09%31,000$6.11M-UnknownUnknown
3JNJJOHNSON AND JOHNSON4.58%22,500$5.50MProProPro
4TMOThermo Fisher Scientific Inc4.25%10,400$5.11MProProPro
5MTDMettler-Toledo International, Inc.3.99%3,800$4.79MProProPro
6GILDGilead Sciences Inc3.48%30,000$4.18MProProPro
7TEVA:TLTeva Pharmaceutical Industries Ltd. (ADR)3.26%130,000$3.92MProProPro
8ISRGIntuitive Surgical Inc - Common3.22%8,400$3.87MProProPro
9ARGXArgenx NV ADR3.16%5,200$3.80MProProPro
10ROIV:BMRoivant Sciences Ltd2.88%125,000$3.46MProProPro
11ELANElanco Animal Health2.84%142,500$3.41MProProPro
12IONSIonis Pharmaceuticals, Inc. Com USD0.0012.81%45,000$3.38MProProPro
13RDNTRadnet Inc2.79%60,000$3.35MProProPro
14VRTXVertex Pharmaceuticals Inc2.79%7,500$3.35MProProPro
15INSMInsmed Inc.(insm)2.72%20,000$3.27MProProPro
See the other 26 holdings of BHCUX
Every position with sector, industry and share changes, as reported Mar 31, 2026.
Get FundXLS Pro: $29/moFirst 500 subscribers, then $49/mo. Cancel anytime.

BHCUX Mutual Fund All Holdings

BHCUX holdings total 41 positions. The top 10 holdings account for 43.9% of the fund, led by Eli Lilly And Company at 9.9%, Astrazeneca Plc Adr at 5.1%, JOHNSON AND JOHNSON at 4.6%.

BHCUX portfolio concentration is moderate, with the top 10 representing 43.9% of total assets. The largest sector exposure is Health Care at 81.7%.

BHCUX sector allocation provides a detailed breakdown. BHCUX overlap tool shows how holdings compare to other funds in your portfolio.